vs
BioNTech SE（BNTX）与Take-Two Interactive（TTWO）财务数据对比。点击上方公司名可切换其他公司
Take-Two Interactive的季度营收约是BioNTech SE的1.1倍（$1.7B vs $1.5B），BioNTech SE净利率更高（-1.9% vs -5.5%，领先3.6%）
BioNTech SE是总部位于德国美因茨的跨国生物技术企业，专注于免疫疗法及疫苗研发工作，核心研究方向覆盖肿瘤、传染性疾病等医疗领域，相关技术处于全球生物医药行业领先水平。
Take-Two Interactive是总部位于美国纽约的电子游戏控股企业，由瑞安·布兰特于1993年9月创立，在全球互动娱乐领域拥有较高影响力，业务覆盖游戏研发、发行与运营等核心环节。
BNTX vs TTWO — 直观对比
营收规模更大
TTWO
是对方的1.1倍
$1.5B
净利率更高
BNTX
高出3.6%
-5.5%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.7B |
| 净利润 | $-28.7M | $-92.9M |
| 毛利率 | — | 55.7% |
| 营业利润率 | -3.1% | -2.3% |
| 净利率 | -1.9% | -5.5% |
| 营收同比 | — | 24.9% |
| 净利润同比 | — | 25.8% |
| 每股收益（稀释后） | — | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNTXTTWO
| Q4 25 | — | $1.7B | ||
| Q3 25 | $1.5B | $1.8B | ||
| Q2 25 | $260.8M | $1.5B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $1.2B | $1.4B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.4B |
净利润BNTXTTWO
| Q4 25 | — | $-92.9M | ||
| Q3 25 | $-28.7M | $-133.9M | ||
| Q2 25 | $-386.6M | $-11.9M | ||
| Q1 25 | — | $-3.7B | ||
| Q4 24 | — | $-125.2M | ||
| Q3 24 | $198.1M | $-365.5M | ||
| Q2 24 | — | $-262.0M | ||
| Q1 24 | — | $-2.9B |
毛利率BNTXTTWO
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 55.3% | ||
| Q2 25 | — | 62.8% | ||
| Q1 25 | — | 50.8% | ||
| Q4 24 | — | 55.9% | ||
| Q3 24 | — | 53.8% | ||
| Q2 24 | — | 57.6% | ||
| Q1 24 | — | 33.5% |
营业利润率BNTXTTWO
| Q4 25 | — | -2.3% | ||
| Q3 25 | -3.1% | -5.5% | ||
| Q2 25 | -192.1% | 1.4% | ||
| Q1 25 | — | -238.7% | ||
| Q4 24 | — | -9.7% | ||
| Q3 24 | 0.8% | -22.0% | ||
| Q2 24 | — | -13.8% | ||
| Q1 24 | — | -193.9% |
净利率BNTXTTWO
| Q4 25 | — | -5.5% | ||
| Q3 25 | -1.9% | -7.5% | ||
| Q2 25 | -148.2% | -0.8% | ||
| Q1 25 | — | -235.5% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | 15.9% | -27.0% | ||
| Q2 24 | — | -19.6% | ||
| Q1 24 | — | -207.4% |
每股收益（稀释后）BNTXTTWO
| Q4 25 | — | $-0.50 | ||
| Q3 25 | — | $-0.73 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-21.27 | ||
| Q4 24 | — | $-0.71 | ||
| Q3 24 | — | $-2.08 | ||
| Q2 24 | — | $-1.52 | ||
| Q1 24 | — | $-17.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $2.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $3.5B |
| 总资产 | — | $10.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BNTXTTWO
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $879.6M | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $776.0M |
股东权益BNTXTTWO
| Q4 25 | — | $3.5B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | — | $3.5B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $5.7B | ||
| Q3 24 | — | $5.8B | ||
| Q2 24 | — | $6.0B | ||
| Q1 24 | — | $5.7B |
总资产BNTXTTWO
| Q4 25 | — | $10.0B | ||
| Q3 25 | — | $10.1B | ||
| Q2 25 | — | $9.7B | ||
| Q1 25 | — | $9.2B | ||
| Q4 24 | — | $12.7B | ||
| Q3 24 | — | $13.1B | ||
| Q2 24 | — | $12.9B | ||
| Q1 24 | — | $12.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $305.2M |
| 自由现金流经营现金流 - 资本支出 | — | $236.2M |
| 自由现金流率自由现金流/营收 | — | 13.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $487.8M |
8季度趋势，按日历期对齐
经营现金流BNTXTTWO
| Q4 25 | — | $305.2M | ||
| Q3 25 | — | $128.4M | ||
| Q2 25 | — | $-44.7M | ||
| Q1 25 | — | $279.0M | ||
| Q4 24 | — | $-4.8M | ||
| Q3 24 | — | $-128.4M | ||
| Q2 24 | — | $-191.0M | ||
| Q1 24 | — | $-8.9M |
自由现金流BNTXTTWO
| Q4 25 | — | $236.2M | ||
| Q3 25 | — | $96.5M | ||
| Q2 25 | — | $-69.8M | ||
| Q1 25 | — | $224.9M | ||
| Q4 24 | — | $-48.2M | ||
| Q3 24 | — | $-165.2M | ||
| Q2 24 | — | $-226.1M | ||
| Q1 24 | — | $-55.1M |
自由现金流率BNTXTTWO
| Q4 25 | — | 13.9% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | -4.6% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | -3.5% | ||
| Q3 24 | — | -12.2% | ||
| Q2 24 | — | -16.9% | ||
| Q1 24 | — | -3.9% |
资本支出强度BNTXTTWO
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 2.6% | ||
| Q1 24 | — | 3.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
